Candel Therapeutics, Inc.CADLNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank33
Studio
Year-over-Year Change

Return on equity

Percentile
P33
Within normal range
vs 5Y Ago
-1x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-73.54%+11.6%
2024-83.19%+72.1%
2023-297.68%-655.7%
2022-39.39%+30.1%
2021-56.32%-175.1%
202075.04%-26.8%
2019102.51%-